Vaccination

FDA panel endorses booster shot for J&J COVID-19 vaccine

U.S. health advisers endorsed a booster of Johnson & Johnson's COVID-19 vaccine Friday, citing concern that Americans who got the single-dose shot aren't as protected as those given two-dose brands.

Medications

FDA to decide on Qnexa obesity drug in July

US regulators will decide in July whether to approve Qnexa, the first obesity drug in more than a decade, extending the initial deadline by three months, the California-based drug-maker VIVUS said.

Health

US dietary guidelines focus on curtailing sugar

The latest word from an advisory panel that helps form U.S. dietary guidelines confirms what nutritionists have been saying in recent years: Cholesterol-rich foods like eggs and shrimp aren't as bad for us as previously believed, ...

Vaccination

US advisers debate Pfizer boosters for younger teens

An influential government advisory panel is considering COVID-19 boosters for younger teens, as the U.S. battles the omicron surge and schools struggle with how to restart classes amid the spike.

Vaccination

Boosters for all adults in US closer with panel meeting set

An influential U.S. advisory panel will discuss expanding eligibility for COVID-19 vaccine booster shots to all adults Friday, a move that could make the shots available nationwide as early as this weekend.

page 6 from 11